2023年韩国放射学会关于放射科人工智能软件用户经验的调查
韩国放射学会于2023年4月17日至5月15日对会员开展匿名在线调查,370名应答者中60.3%有AI-SaMD使用经验,最常用于病灶检测(82.1%)和诊断/分类(55.2%),涉及模态以X线摄影(62.3%)和CT(42.6%)为主,用户满意度较高(67.6%–85.1%),91.9%的应答者认为需要KSR主导的教育或指南。
要点
- 60.3%的应答者有AI-SaMD使用经验,主要用于病灶检测(82.1%)和病灶诊断/分类(55.2%)。
- AI-SaMD应用最多的影像模态为X线摄影(62.3%)、CT(42.6%)、乳腺X线摄影(29.1%)和MRI(28.7%)。
- 91.9%的应答者认为需要KSR主导的AI-SaMD使用教育或指南。
核心结论
- 韩国放射学会会员中AI-SaMD的临床渗透率和满意度均较高,多数AI-SaMD用于病灶检测、诊断和分类,多数应答者要求KSR主导的教育或指南。
研究设计与样本
- 韩国放射学会于2023年4月17日至5月15日面向所有会员的匿名自愿在线调查,共370名应答者(应答率7.7% [370/4792];340名委员会认证放射科医师;210名来自学术机构)。
诊断标准与关键数值
- 60.3%(223/370)的应答者有AI-SaMD使用经验。
- 使用AI-SaMD的应答者中,病灶检测占82.1%(183/223),病灶诊断/分类占55.2%(123/223)。
- 使用AI-SaMD的应答者中,目标影像模态为X线摄影62.3%(139/223)、CT 42.6%(95/223)、乳腺X线摄影29.1%(65/223)、MRI 28.7%(64/223)。
- 用户满意度范围为67.6%(115/170,用于改善患者管理)至85.1%(189/222,用于性能)。
- 关于临床应用扩展,77.0%(285/370)的应答者偏好AI-SaMD辅助检测/诊断,63.5%(235/370)偏好自动测量/定量。
临床应用与阅片要点
- 调查显示AI-SaMD在韩国放射科会员中主要用于病灶检测和诊断/分类,涉及X线摄影、CT、乳腺X线摄影和MRI。
- 多数应答者偏好AI-SaMD辅助检测/诊断和自动测量/定量,并认为未来开发应关注实践效率和质量。
- 多数应答者认为需要KSR主导的AI-SaMD使用教育或指南。
局限性
- 应答率为7.7%(370/4792)。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
英文原文(摘要)· 点击展开
OBJECTIVE: In Korea, radiology has been positioned towards the early adoption of artificial intelligence-based software as medical devices (AI-SaMDs); however, little is known about the current usage, implementation, and future needs of AI-SaMDs. We surveyed the current trends and expectations for AI-SaMDs among members of the Korean Society of Radiology (KSR).
MATERIALS AND METHODS: An anonymous and voluntary online survey was open to all KSR members between April 17 and May 15, 2023. The survey was focused on the experiences of using AI-SaMDs, patterns of usage, levels of satisfaction, and expectations regarding the use of AI-SaMDs, including the roles of the industry, government, and KSR regarding the clinical use of AI-SaMDs.
RESULTS: Among the 370 respondents (response rate: 7.7% [370/4792]; 340 board-certified radiologists; 210 from academic institutions), 60.3% (223/370) had experience using AI-SaMDs. The two most common use-case of AI-SaMDs among the respondents were lesion detection (82.1%, 183/223), lesion diagnosis/classification (55.2%, 123/223), with the target imaging modalities being plain radiography (62.3%, 139/223), CT (42.6%, 95/223), mammography (29.1%, 65/223), and MRI (28.7%, 64/223). Most users were satisfied with AI-SaMDs (67.6% [115/170, for improvement of patient management] to 85.1% [189/222, for performance]). Regarding the expansion of clinical applications, most respondents expressed a preference for AI-SaMDs to assist in detection/diagnosis (77.0%, 285/370) and to perform automated measurement/quantification (63.5%, 235/370). Most respondents indicated that future development of AI-SaMDs should focus on improving practice efficiency (81.9%, 303/370) and quality (71.4%, 264/370). Overall, 91.9% of the respondents (340/370) agreed that there is a need for education or guidelines driven by the KSR regarding the use of AI-SaMDs.
CONCLUSION: The penetration rate of AI-SaMDs in clinical practice and the corresponding satisfaction levels were high among members of the KSR. Most AI-SaMDs have been used for lesion detection, diagnosis, and classification. Most respondents requested KSR-driven education or guidelines on the use of AI-SaMDs.
引用
- Hwang EJ, Park JE, Song KD, et al. 2023 Survey on User Experience of Artificial Intelligence Software in Radiology by the Korean Society of Radiology. Korean J Radiol. 2024. PMID: 38942455. doi:10.3348/kjr.2023.1246
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。